Impact of beta blockers on survival outcomes in ovarian cancer: a nationwide population-based cohort study.
Min Hyun BaekDae-Yeon KimSeon Ok KimYe Jee KimYoung Han ParkPublished in: Journal of gynecologic oncology (2019)
In our nationwide population-based cohort study, BB use was associated with better survival outcomes in ovarian cancer in cases of long term duration of use, in older patients, and in cardiovascular and/or other underlying disease (CCI ≥3).